K. Matsuzaki
Microbiology · 2009–2018
A researcher in the Science corpus: 2 papers; trusts 4 researchers and is trusted by 3 researchers here, as inferred from the citation graph.
Subfields
- Microbiology — 7 citations into it; #83 of 213 by trust here, #185 by citations
Whom K. Matsuzaki trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts K. Matsuzaki overall
Papers from K. Matsuzaki's perspective
Ordered by how strongly the researchers K. Matsuzaki trusts endorse each paper. Same corpus, a different order for every researcher.
- Antimicrobial peptides of multicellular organisms (Nature)
- Mechanisms of Antimicrobial Peptide Action and Resistance (Pharmacological Reviews)
- Effect of pegylation on pharmaceuticals (Nature reviews. Drug discovery)
- Barrel-stave model or toroidal model? A case study on melittin pores. (Biophysical Journal)
- Staphylococcus aureus Resistance to Human Defensins and Evasion of Neutrophil Killing via the Novel Virulence Factor Mprf Is Based on Modification of Membrane Lipids with l-Lysine (Journal of Experimental Medicine)
- The Pleiotropic Two-Component Regulatory System PhoP-PhoQ (Journal of Bacteriology)
- Chemistry for peptide and protein PEGylation. (Advanced Drug Delivery Reviews)
- Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. (New England Journal of Medicine)
- Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. (The Lancet)
- Antimicrobials: access and sustainable eff ectiveness 2 Understanding the mechanisms and drivers of antimicrobial resistance
Their papers
- Control of cell selectivity of antimicrobial peptides. (2009) — 662 citations
- High performance plasma amyloid-β biomarkers for Alzheimer’s disease (2018) — 1,471 citations